SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Boston Scientific Corp. – ‘8-K’ for 3/1/21 – ‘XML’

On:  Monday, 3/1/21, at 4:15pm ET   ·   For:  3/1/21   ·   Accession #:  1104659-21-29993   ·   File #:  1-11083

Previous ‘8-K’:  ‘8-K’ on / for 2/3/21   ·   Next:  ‘8-K’ on / for 3/3/21   ·   Latest:  ‘8-K’ on 4/4/24 for 4/3/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/01/21  Boston Scientific Corp.           8-K:8,9     3/01/21   11:241K                                   Toppan Merrill/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     34K 
 7: R1          Cover                                               HTML     53K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- tm218230d1_8k_htm                   XML     21K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.DEF  XBRL Definitions -- bsx-20210301_def                 XML     75K 
 4: EX-101.LAB  XBRL Labels -- bsx-20210301_lab                      XML    104K 
 5: EX-101.PRE  XBRL Presentations -- bsx-20210301_pre               XML     72K 
 2: EX-101.SCH  XBRL Schema -- bsx-20210301                          XSD     14K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               27±    36K 
11: ZIP         XBRL Zipped Folder -- 0001104659-21-029993-xbrl      Zip     15K

‘XML’   —   XBRL Instance — tm218230d1_8k_htm

This Document is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:bsx="http://bostonscientific.com/20210301" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="bsx-20210301.xsd" xlink:type="simple"/>
<context id="From2021-03-01to2021-03-01">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000885725 </identifier>
</entity>
<period>
<startDate> 2021-03-01 </startDate>
<endDate> 2021-03-01 </endDate>
</period>
</context>
<context id="From2021-03-012021-03-01_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000885725 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-03-01 </startDate>
<endDate> 2021-03-01 </endDate>
</period>
</context>
<context id="From2021-03-012021-03-01_custom_SeniorNoteDue2027Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000885725 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> bsx:SeniorNoteDue2027Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-03-01 </startDate>
<endDate> 2021-03-01 </endDate>
</period>
</context>
<context id="From2021-03-012021-03-01_custom_A550MCPSSeriesAMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000885725 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> bsx:A550MCPSSeriesAMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-03-01 </startDate>
<endDate> 2021-03-01 </endDate>
</period>
</context>
<unit id="USD">
<measure> iso4217:USD </measure>
</unit>
<unit id="Shares">
<measure> shares </measure>
</unit>
<unit id="USDPShares">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<dei:EntityCentralIndexKey contextRef="From2021-03-01to2021-03-01"> 0000885725 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="From2021-03-01to2021-03-01"> false </dei:AmendmentFlag>
<dei:DocumentType contextRef="From2021-03-01to2021-03-01"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="From2021-03-01to2021-03-01"> 2021-03-01 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="From2021-03-01to2021-03-01"> BOSTON SCIENTIFIC CORPORATION </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="From2021-03-01to2021-03-01"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="From2021-03-01to2021-03-01"> 1-11083 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="From2021-03-01to2021-03-01"> 04-2695240 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="From2021-03-01to2021-03-01"> 300 Boston Scientific Way </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="From2021-03-01to2021-03-01"> Marlborough </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="From2021-03-01to2021-03-01"> MA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="From2021-03-01to2021-03-01"> 01752-1234 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="From2021-03-01to2021-03-01"> 508 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="From2021-03-01to2021-03-01"> 683-4000 </dei:LocalPhoneNumber>
<dei:WrittenCommunications contextRef="From2021-03-01to2021-03-01"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="From2021-03-01to2021-03-01"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="From2021-03-01to2021-03-01"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="From2021-03-01to2021-03-01"> false </dei:PreCommencementIssuerTenderOffer>
<dei:Security12bTitle contextRef="From2021-03-012021-03-01_us-gaap_CommonStockMember"> Common Stock, $0.01 par value per share </dei:Security12bTitle>
<dei:TradingSymbol contextRef="From2021-03-012021-03-01_us-gaap_CommonStockMember"> BSX </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="From2021-03-012021-03-01_us-gaap_CommonStockMember"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="From2021-03-012021-03-01_custom_SeniorNoteDue2027Member"> 0.625% Senior Notes due 2027 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="From2021-03-012021-03-01_custom_SeniorNoteDue2027Member"> BSX27 </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="From2021-03-012021-03-01_custom_SeniorNoteDue2027Member"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="From2021-03-012021-03-01_custom_A550MCPSSeriesAMember"> 5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share </dei:Security12bTitle>
<dei:TradingSymbol contextRef="From2021-03-012021-03-01_custom_A550MCPSSeriesAMember"> BSX PR A </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="From2021-03-012021-03-01_custom_A550MCPSSeriesAMember"> NYSE </dei:SecurityExchangeName>
<dei:EntityEmergingGrowthCompany contextRef="From2021-03-01to2021-03-01"> false </dei:EntityEmergingGrowthCompany>
</xbrl>

↑Top
Filing Submission 0001104659-21-029993   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., Apr. 19, 9:18:36.1pm ET